Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

This study has been completed.
Sponsor:
Collaborators:
Genitope Corporation
Information provided by:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00004198
First received: January 21, 2000
Last updated: June 23, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Primary Completion Date: January 2002 (Final data collection date for primary outcome measure)